Please wait a minute...
European Journal of Gynaecological Oncology  2019, Vol. 40 Issue (4): 676-678    DOI: 10.12892/ejgo4555.2019
Case Report Previous articles | Next articles
Small cell carcinoma of the endometrium mixed with endometriod adenocarcinoma: a case report
X. Lyu1, P. Liu1, *(), H. Mao1, B. Han1, X. Wei1
1 Department of Obstetrics and Gynecology, QiLu Hospital, Shandong University, Ji'nan, Shandong, China
Download:  PDF(1059KB)  ( 198 ) Full text   ( 11 )
Export:  BibTeX | EndNote (RIS)      
Abstract  
Small cell neuroendocrine carcinoma of the female genital tract is very rare, with highly aggressiveness and poor clinical outcome. It can be mostly found in the cervix, followed by the ovaries. Endometrial small cell carcinoma (SCC) is extremely rare in perimenopausal or postmenopausal women. Here, the authors present a case of a 59-year-old postmenopausal woman, who had experienced vaginal bleeding and abdominal pain for a long time. After undergoing a hysteroscopy-guided biopsy which revealed small cell neuroendocrine carcinoma of the endometrium, she received a total abdominal hysterectomy with bilateral salpingo-oophorectomy, pelvic lymphadenectomy, and para-aortic lymphadenectomy. Her final FIGO Stage was IA. Recommendation from the tumor board was chemotherapy treatment after surgery, but this patient refused to take any measures. The patient experienced no indication of a tumor in the abdomen 14 months after the diagnosis. Endometrial small carcinoma is a very rare and aggressive cancer. The prognosis is unfavorable but timely surgical treatment and early pathological stage may improve the clinical outcome.
Key words:  Small cell carcinoma      Endometrium      Endometrial cancer      Immunohistochemical staining     
Published:  10 August 2019     
*Corresponding Author(s):  P. LIU     E-mail:  peishuliu@126.com

Cite this article: 

X. Lyu, P. Liu, H. Mao, B. Han, X. Wei. Small cell carcinoma of the endometrium mixed with endometriod adenocarcinoma: a case report. European Journal of Gynaecological Oncology, 2019, 40(4): 676-678.

URL: 

https://ejgo.imrpress.com/EN/10.12892/ejgo4555.2019     OR     https://ejgo.imrpress.com/EN/Y2019/V40/I4/676

[1] Ikuji Shimazaki, Yasunori Hashiguchi, Makoto Yamauchi, Mari Kasai, Takeshi Fukuda, Tomoyuki Ichimura, Tomoyo Yasui, Toshiyuki Sumi. Secondary small cell vaginal cancer after operative therapy for endometrial cancer[J]. European Journal of Gynaecological Oncology, 2020, 41(5): 821-823.
[2] Jaudah Al-Maghrabi, Haneen Al-Maghrabi. SIRT1 is overexpressed in endometrial adenocarcinoma: a tissue microarray analysis[J]. European Journal of Gynaecological Oncology, 2020, 41(5): 699-704.
[3] Yu Hui Lim, Sheow Lei Lim, Linda Xiao Hui Lin, Lay Tin Soh, Hoon Seng Khoo Tan, Richard Ming Chert Yeo, Timothy Yong Kuei Lim. Sequential Chemoradiation versus Radiation for the Adjuvant Treatment of Stage III Endometrioid Adenocarcinoma of the Uterus[J]. European Journal of Gynaecological Oncology, 2020, 41(5): 705-712.
[4] Eda Kucuktulu, Ahmet Fatih Yurekli. Simultaneous Integrated Intensity Modulated Radiotherapy Boost for Gynecological Cancer when Brachytherapy is not an Option[J]. European Journal of Gynaecological Oncology, 2020, 41(5): 720-725.
[5] Michelle F. Benoit, Kristy K. Ward. Uterine Cancer Normogram to Predict Lymph Node Metastasis: Comparison to the Mayo Algorithm and an External Validation of a Model in a North American Population[J]. European Journal of Gynaecological Oncology, 2020, 41(5): 681-684.
[6] Yusuf Cakmak, Tufan Oge. The effect of age on prediction of concurrent endometrial cancer in patients with atypical endometrial hyperplasia[J]. European Journal of Gynaecological Oncology, 2020, 41(4): 531-535.
[7] Di Wu, Jirui Zhang, Chengxi Yang. Effect of letrozole combined with testosterone on the proliferation and apoptosis of endometrial carcinoma cells[J]. European Journal of Gynaecological Oncology, 2020, 41(4): 604-608.
[8] B.-H. Zhang, L. Li, J. Ji, J. Guo, X.-L. Zhou, H. Xu, F. Cao, X.-H. Tong. Prognostic value of Foxp3+ regulatory T cells in endometrial cancer: a meta-analysis[J]. European Journal of Gynaecological Oncology, 2020, 41(3): 339-342.
[9] Marcin Jedryka, Agnieszka Chrobak, Anna Chelmonska-Soyta, Daria Fijalkowska, Rafal Matkowski. Decreased expression of estrogen receptors alpha and beta in peripheral blood lymphocytes from the endometrial cancer patients and women with endometriosis[J]. European Journal of Gynaecological Oncology, 2020, 41(3): 375-379.
[10] J.Y. Chen, Z.Q. Wang, S.C. Liang, H.Y. Hou, D.B. Chen, J.L. Wang. Sentinel lymph node mapping with carbon nanoparticles in endometrial cancer[J]. European Journal of Gynaecological Oncology, 2020, 41(3): 408-414.
[11] J. Feng, J. Wu, M. Zhang, J. Wang, K. Chen, X. Li, J. Xie, J. Zhang, C. Wang. Oleic acid promotes the development of endometrial cancer by up-regulating KLF4 expression[J]. European Journal of Gynaecological Oncology, 2020, 41(3): 432-438.
[12] S. Liu, F. Ruan, M. Shi, Y. Liu, W. Li, B. Bi, H. Wang, W. Lv. Safe fertility-preserving management in a young woman with endometrial cancer[J]. European Journal of Gynaecological Oncology, 2020, 41(3): 476-479.
[13] H. Cokmez, A. Yilmaz. Concordance of preoperative and postoperative histological grades in endometrioid type endometrial cancer[J]. European Journal of Gynaecological Oncology, 2020, 41(2): 208-213.
[14] K. Plagens–Rotman, M. Piskorz–Szymendera, B. PIĘTA. Lifestyle with particular emphasis on physical activity and genital carcinomas in women[J]. European Journal of Gynaecological Oncology, 2020, 41(2): 233-239.
[15] X. Guo, Z. Cheng, L. Liang, M. Shao, H. Jin, J. Luo. Small cell carcinoma of the ovary hypercalcemic type (SCCOHT): report of three cases and literature review[J]. European Journal of Gynaecological Oncology, 2020, 41(2): 303-307.
No Suggested Reading articles found!